Request Deal Involvement
Knight Therapeutics completed the acquisition of Paladin Pharma from Endo for $105m.
Identify your role
Select the side you represented in this transaction, and provide your current job title.
Service Providers
legal advisors
Davis Polk & Wardwell
legal advisors
A&L Goodbody
financial advisors
RBC Capital Markets
legal advisors
Davies Ward Phillips & Vineberg
or
Principals
target
PALADIN PHARMA INC
vendor
ENDO INTERNATIONAL PLC
bidder
KNIGHT THERAPEUTICS INC
Principals or Service Provider not listed?Add missing Service Provider or Principal
Enter your Job Title on this deal
This title will appear on your profile next to this deal involvement.
To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:
All rights reserved. Copyright © 2026 Datasite